Forte Biosciences Inc expected to post a loss of 16 cents a share - Earnings Preview

Forte Biosciences

10/05/2024 12:25

* Forte Biosciences Inc  FBRX.OQ   FBRX.O  is expected
to report
resultson May 13 (estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Forte Biosciences Inc is
for a
loss of 16 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Forte
Biosciences
Inc is $2.88​, above​ its last closing price of $0.73. ​​​

This summary was machine generated May 10 at 11:25 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)